Yangjun Wu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
-
- RNA modifications and cancer
- RNA Research and Splicing
- Circular RNAs in diseases
- RNA and protein synthesis mechanisms
Papers in
-
- RNA modifications and cancer 9
- RNA Research and Splicing 5
- Circular RNAs in diseases 4
- RNA and protein synthesis mechanisms 2
-
- Cancer-related molecular mechanisms research 12
- MicroRNA in disease regulation 1
- Co-authors
- Shenglin Huang (8 shared papers)Lin Huan (6 shared papers)Linhui Liang (8 shared papers)Xianghuo He (8 shared papers)Linguo Xu (4 shared papers)Tianan Guo (2 shared papers)Ye Xu (2 shared papers)Yuqiang Zhou (3 shared papers)
- Journals
- Cancer Letters (2 papers)Molecular Cancer (2 papers)Molecular Therapy — Nucleic Acids (1 paper)Nature Communications (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Yangjun Wu
20 papers receiving 532 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 384
- Molecular Biology 430
- Oncology 46
- Immunology 32
- Pulmonary and Respiratory Medicine 42
Countries citing papers authored by Yangjun Wu
This map shows the geographic impact of Yangjun Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangjun Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangjun Wu more than expected).
Fields of papers citing papers by Yangjun Wu
This network shows the impact of papers produced by Yangjun Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangjun Wu. The network helps show where Yangjun Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yangjun Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 123 | |
| 2 | 2020 | 69 | |
| 3 | 2019 | 66 | |
| 4 | 2019 | 60 | |
| 5 | 2019 | 50 | |
| 6 | 2019 | 46 | |
| 7 | 2021 | 22 | |
| 8 | 2022 | 20 | |
| 9 | 2023 | 17 | |
| 10 | 2021 | 15 | |
| 11 | 2022 | 11 | |
| 12 | 2023 | 10 | |
| 13 | 2023 | 8 | |
| 14 | 2024 | 7 | |
| 15 | 2024 | 4 | |
| 16 | 2021 | 4 | |
| 17 | 2025 | 2 | |
| 18 | 2025 | 1 | |
| 19 | [Modelling and kinetic analysis on changrolin block of cardiac Na+ channels]. | 1991 | 1 |
| 20 | Mechanisms of action of sodium channel blocker: gate-related receptor hypothesis. | 1992 | 1 |
About Yangjun Wu
Yangjun Wu is a scholar working on Molecular Biology, Cancer Research, Oncology, Materials Chemistry and Organic Chemistry, having authored 22 papers that have together received 537 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (9 papers), RNA Research and Splicing (5 papers), Circular RNAs in diseases (4 papers), Machine Learning in Materials Science (2 papers), PARP inhibition in cancer therapy (2 papers), RNA and protein synthesis mechanisms (2 papers) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Cancer Research (384 citations), Molecular Biology (430 citations), Oncology (46 citations), Immunology (32 citations) and Pulmonary and Respiratory Medicine (42 citations). Yangjun Wu has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Shenglin Huang, Lin Huan, Linhui Liang, Xianghuo He, Linguo Xu, Tianan Guo, Ye Xu, Yuqiang Zhou, Shengli Li and Lu Wang. Their work appears in journals such as Cancer Letters, Molecular Cancer, Molecular Therapy — Nucleic Acids, Nature Communications and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.